These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 31506828)

  • 1. Reducing Viral Inhibition of Host Cellular Apoptosis Strengthens the Immunogenicity and Protective Efficacy of an Attenuated HSV-1 Strain.
    Xu X; He Y; Fan S; Feng M; Jiang G; Wang L; Zhang Y; Liao Y; Li Q
    Virol Sin; 2019 Dec; 34(6):673-687. PubMed ID: 31506828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes simplex virus genes Us3, Us5, and Us12 differentially regulate cytotoxic T lymphocyte-induced cytotoxicity.
    Aubert M; Krantz EM; Jerome KR
    Viral Immunol; 2006; 19(3):391-408. PubMed ID: 16987059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A HSV1 mutant leads to an attenuated phenotype and induces immunity with a protective effect.
    Xu X; Feng X; Wang L; Yi T; Zheng L; Jiang G; Fan S; Liao Y; Feng M; Zhang Y; Li D; Li Q
    PLoS Pathog; 2020 Aug; 16(8):e1008703. PubMed ID: 32776994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpes Simplex Virus 1 (HSV-1) 0ΔNLS Live-Attenuated Vaccine Protects against Ocular HSV-1 Infection in the Absence of Neutralizing Antibody in HSV-1 gB T Cell Receptor-Specific Transgenic Mice.
    Gmyrek GB; Filiberti A; Montgomery M; Chitrakar A; Royer DJ; Carr DJJ
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32999018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes simplex virus inhibits apoptosis through the action of two genes, Us5 and Us3.
    Jerome KR; Fox R; Chen Z; Sears AE; Lee Hy; Corey L
    J Virol; 1999 Nov; 73(11):8950-7. PubMed ID: 10516000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An HSV-1 gD mutant virus as an entry-impaired live virus vaccine.
    Awasthi S; Lubinski JM; Eisenberg RJ; Cohen GH; Friedman HM
    Vaccine; 2008 Feb; 26(9):1195-203. PubMed ID: 18243431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
    J Virol; 2017 May; 91(9):. PubMed ID: 28228587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease.
    Davido DJ; Tu EM; Wang H; Korom M; Gazquez Casals A; Reddy PJ; Mostafa HH; Combs B; Haenchen SD; Morrison LA
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29950407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective immunity against lethal HSV-1 challenge in mice by nucleic acid-based immunisation with herpes simplex virus type-1 genes specifying glycoproteins gB and gD.
    Baghian A; Chouljenko VN; D'Auvergne O; Newman MJ; Baghian S; Kousoulas KG
    J Med Microbiol; 2002 Apr; 51(4):350-357. PubMed ID: 11926742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and properties of a herpes simplex virus 2 dl5-29 vaccine candidate strain encoding an HSV-1 virion host shutoff protein.
    Reszka NJ; Dudek T; Knipe DM
    Vaccine; 2010 Mar; 28(15):2754-62. PubMed ID: 20117270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Us3 kinase encoded by herpes simplex virus 1 mediates downregulation of cell surface major histocompatibility complex class I and evasion of CD8+ T cells.
    Imai T; Koyanagi N; Ogawa R; Shindo K; Suenaga T; Sato A; Arii J; Kato A; Kiyono H; Arase H; Kawaguchi Y
    PLoS One; 2013; 8(8):e72050. PubMed ID: 23951282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a Herpes Simplex Virus 1 (HSV-1) Chimera in Which the Us3 Protein Kinase Gene Is Replaced with the HSV-2 Us3 Gene.
    Shindo K; Kato A; Koyanagi N; Sagara H; Arii J; Kawaguchi Y
    J Virol; 2016 Jan; 90(1):457-73. PubMed ID: 26491159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of virion host shutoff activity improves the immunogenicity and protective capacity of a replication-incompetent herpes simplex virus type 1 vaccine strain.
    Geiss BJ; Smith TJ; Leib DA; Morrison LA
    J Virol; 2000 Dec; 74(23):11137-44. PubMed ID: 11070010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Type I Interferon on the Safety and Immunogenicity of an Experimental Live-Attenuated Herpes Simplex Virus 1 Vaccine in Mice.
    Royer DJ; Carr MM; Chucair-Elliott AJ; Halford WP; Carr DJJ
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28122977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic immunization with a virion host shutoff-defective, replication-incompetent herpes simplex virus type 1 strain limits recurrent herpetic ocular infection.
    Keadle TL; Morrison LA; Morris JL; Pepose JS; Stuart PM
    J Virol; 2002 Apr; 76(8):3615-25. PubMed ID: 11907201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of a herpes simplex virus 1 dUTPase by a viral protein kinase, Us3, dictates viral pathogenicity in the central nervous system but not at the periphery.
    Kato A; Shindo K; Maruzuru Y; Kawaguchi Y
    J Virol; 2014 Mar; 88(5):2775-85. PubMed ID: 24352467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single intramuscular vaccination of mice with the HSV-1 VC2 virus with mutations in the glycoprotein K and the membrane protein UL20 confers full protection against lethal intravaginal challenge with virulent HSV-1 and HSV-2 strains.
    Stanfield BA; Stahl J; Chouljenko VN; Subramanian R; Charles AS; Saied AA; Walker JD; Kousoulas KG
    PLoS One; 2014; 9(10):e109890. PubMed ID: 25350288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant herpes simplex virus type 1 (HSV-1) codelivering interleukin-12p35 as a molecular adjuvant enhances the protective immune response against ocular HSV-1 challenge.
    Osorio Y; Ghiasi H
    J Virol; 2005 Mar; 79(6):3297-308. PubMed ID: 15731224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An attenuated herpes simplex virus type 1 (HSV1) encoding the HIV-1 Tat protein protects mice from a deadly mucosal HSV1 challenge.
    Sicurella M; Nicoli F; Gallerani E; Volpi I; Berto E; Finessi V; Destro F; Manservigi R; Cafaro A; Ensoli B; Caputo A; Gavioli R; Marconi PC
    PLoS One; 2014; 9(7):e100844. PubMed ID: 25033084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The US3 Kinase of Herpes Simplex Virus Phosphorylates the RNA Sensor RIG-I To Suppress Innate Immunity.
    van Gent M; Chiang JJ; Muppala S; Chiang C; Azab W; Kattenhorn L; Knipe DM; Osterrieder N; Gack MU
    J Virol; 2022 Feb; 96(4):e0151021. PubMed ID: 34935440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.